asco 2008: cetuximab for nsclc
Published 14 years ago • 200 plays • Length 6:35Download video MP4
Download video MP3
Similar videos
-
7:03
asco 2008: cetuximab for nsclc
-
4:54
asco 2008: cetuximab studies in mcrc
-
5:53
asco 2008: cetuximab and docetaxal for squamous cell cancer
-
6:29
asco 2008: cetuximab for metastatic colorectal cancer (mcrc)
-
3:56
esmo sweden 2008: chemotherapy, radiotherapy and cetuximab in head and neck cancer.
-
3:59
asco: erbitux gives extra time to advanced lung cancer
-
3:59
asco 2013: cetuximab superior to bevacizumab for advanced colorectal cancer
-
11:15
bevacizumab and cetuximab (plus chemotherapy) equally effective for colorectal cancer patients
-
16:20
has cetuximab "selected" out in the treatment of nsclc? - dr. edward s. kim
-
8:34
esmo sweden 2008: gene marker indicates doubling of survival time in cetuximab-treated crc
-
0:51
dr. west discusses afatinib and cetuximab combination in nsclc
-
8:19
cetuximab use for hnscc
-
7:25
lung cancer highlights from asco 2017 | john heymach
-
1:08
dr. weinberg on the role of cetuximab in metastatic crc
-
4:42
volfi trial final results: mfolfoxiri and panitumumab versus folfoxiri in ecog 0-1 and primarily...
-
2:15
rtog 0617: radiation with concurrent chemotherapy and cetuximab in nsclc
-
8:38
afatinib plus cetuximab in resistant non-small cell lung cancer
-
7:28
egfrm nsclc: should we treat with durvalumab? - asco lung review 2022
-
0:56
dr. bekaii-saab on tolerability of encorafenib, binimetinib, and cetuximab in braf crc